Limited Treatment Response during Follow-up after Switching to Aflibercept in Neovascular Age-related Macular Degeneration
Gon Soo Choe, Jong Woo Kim, Chul Gu Kim, Jae Hui Kim
J Korean Ophthalmol Soc. 2021;62(9):1218-1226.   Published online 2021 Sep 15     DOI: https://doi.org/10.3341/jkos.2021.62.9.1218
Citations to this article as recorded by Crossref logo
Outcome of Aflibercept-Bevacizumab Alternate Dosing in Neovascular Age-related Macular Degeneration with Limited Response to Aflibercept
Daeun Shin, Jae Hui Kim
Journal of the Korean Ophthalmological Society.2022; 63(6): 526.     CrossRef